Primary Peritoneal Perivesical Hemangiosarcoma in 16 Dogs (2020–2024)
Veterinary Medicine and Science · 2026
DOI: 10.1002/vms3.71094 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Veterinary Medicine and Science, 2026. Verfasst von Jose Roca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Service Anicura Glòries Hospital Veterinari, Barcelona, Spain. Hauptthemen laut MEDLINE: Hemangiosarcoma, Dog Diseases, Peritoneal Neoplasms. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Canine hemangiosarcoma (HSA) commonly arises in the spleen, heart, and skin, whereas primary peritoneal presentations are rare and poorly characterized. A perivesical peritoneal location without involvement of adjacent organs has not been previously well described.
Objective
This study aims to characterize the clinical presentation, diagnostic features, treatment, and outcomes of dogs with primary peritoneal perivesical HSA. Animals This study included 16 client‐owned dogs diagnosed with peritoneal perivesical HSA at 2 referral centres between 2020 and 2024.
Methods
Methods consisted of retrospective multicentre case series. Medical records were reviewed for clinical signs, laboratory abnormalities, imaging findings, diagnostic procedures, treatment, metastatic status, and outcome measures, including progression‐free survival (PFS) and disease‐specific survival time (DSST).
Results
Common presenting signs included lethargy, hyporexia, pale mucous membranes, and abdominal distension. Hemoperitoneum was identified in 50% of the dogs. Frequent laboratory abnormalities included anaemia, thrombocytopenia, neutrophilia, and azotaemia. All dogs had a mass adjacent to the urinary bladder without evidence of origin from surrounding organs. Diagnosis was achieved by cytology or histopathology. Metastatic disease was suspected at diagnosis in 56.25% of the dogs, most commonly affecting the lungs, and the overall metastatic rate was 87.5%. Treatment protocols included chemotherapy alone ( n = 8), surgery with adjuvant chemotherapy ( n = 7), and neoadjuvant chemotherapy followed by surgery ( n = 1). All surgical procedures consisted of debulking surgery. Chemotherapy alone resulted in a 55.55% partial response rate. Mean PFS and DSST were both 125 days. Combination therapy, response to chemotherapy, and rescue treatment were significantly associated with improved DSST.
Conclusions
Primary peritoneal perivesical HSA may represent a distinct anatomical presentation of canine HSA. Multimodal treatment strategies may improve clinical outcomes and survival in affected dogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Service Anicura Glòries Hospital Veterinari, Barcelona, Spain.
- Oncology Service Hospital Aúna Especialidades Veterinarias IVC Evidensia, Paterna, Spain.
ORCID-Profile: Jose Roca
Zitieren
APA
Roca, J., Escoda, X., García-de la Virgen, M., & Rodríguez, I. (2026). Primary Peritoneal Perivesical Hemangiosarcoma in 16 Dogs (2020–2024). Veterinary Medicine and Science. https://doi.org/10.1002/vms3.71094
Vancouver
Roca J, Escoda X, García-de la Virgen M, Rodríguez I. Primary Peritoneal Perivesical Hemangiosarcoma in 16 Dogs (2020–2024). Veterinary Medicine and Science. 2026. doi:10.1002/vms3.71094
BibTeX
@article{Roca2026,
author = {Roca, Jose and Escoda, Xavier and García-de la Virgen, Miguel and Rodríguez, Ignasi},
title = {Primary Peritoneal Perivesical Hemangiosarcoma in 16 Dogs (2020–2024)},
journal = {Veterinary Medicine and Science},
year = {2026},
doi = {10.1002/vms3.71094}
}
EUVIMED